Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aceso Life Science Group (HKSE:00474) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Aceso Life Science Group Net Margin % Related Terms
Aceso Life Science Group Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00474 vs URI, SUNB, AER: Net Margin % Comparison
For the Rental & Leasing Services subindustry, Aceso Life Science Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aceso Life Science Group Net Margin % vs Business Services Industry
For the Business Services industry and Industrials sector, Aceso Life Science Group's Net Margin % distribution charts can be found below:
* The bar in red indicates where Aceso Life Science Group's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aceso Life Science Group (HKSE:00474) has a Net Margin % of 1,331.03% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Aceso Life Science Group and its competitors. According to the industry distribution chart, Aceso Life Science Group ranks #1050 out of 1071 companies in the Business Services industry, placing it in the top 98%.
Is Aceso Life Science Group's Net Margin % too high?
Aceso Life Science Group's current Net Margin % is 1,331.03%. The Business Services industry median Net Margin % is 3.89. Aceso Life Science Group's value of 1,331.03% is 34116.7% above this industry median. Based on the distribution chart, Aceso Life Science Group ranks #1050 out of 1071 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Aceso Life Science Group has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aceso Life Science Group's Net Margin % compare to URI and SUNB?
According to the Business Services industry distribution chart, Aceso Life Science Group ranks #1050 out of 1071 companies for Net Margin %. This places Aceso Life Science Group in the lower half of its industry. The industry median Net Margin % is 3.89. Aceso Life Science Group's value of 1,331.03% is 34116.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Business Services company?
The median Net Margin % among Business Services companies is 3.89, based on 1,071 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aceso Life Science Group's current Net Margin % of 1,331.03% is 34116.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aceso Life Science Group and its competitors. For the Business Services industry, the median Net Margin % is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aceso Life Science Group's current Net Margin % is 1,331.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aceso Life Science Group stock overvalued right now?
Based on GuruFocus' analysis, Aceso Life Science Group (HKSE:00474) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.11 — trading 42.5% above its estimated fair value. The current Net Margin % is 1,331.03% and 34116.7% above the Business Services industry median of 3.89. Aceso Life Science Group's overall GF Score™ is 19/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aceso Life Science Group (HKSE:00474), the current Net Margin % is 1,331.03% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aceso Life Science Group (HKSE:00474) Overvalued in 2026?
Based on GuruFocus' analysis, Aceso Life Science Group stock appears to be overvalued.
The current stock price of HK$0.11 is trading 42.5% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Aceso Life Science Group to be Significantly Overvalued.
Key valuation signals for HKSE:00474:
Net Margin %: 1,331.03%
GF Value™: HK$0.08 vs. price of HK$0.11 (42.5% above fair value)
Industry Position: 34116.7% above the Business Services median (#1050 of 1071)
No single metric tells the full story. See the HKSE:00474 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
19GF Score
Get the complete analysis for HKSE:00474
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00474 has been successfully added to your 
